ViferaXS Secures €12 Million Funding to Propel Cancer Immunotherapy Trials #Germany #cancer_therapy #Tübingen #ViferaXS #CLLTAXS01
@newsen.bsky.socialExplore
@newsen.bsky.social
@newsen.bsky.socialViferaXS Secures €12 Million Funding to Propel Cancer Immunotherapy Trials #Germany #cancer_therapy #Tübingen #ViferaXS #CLLTAXS01